Showing results (1331-1340 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|March 26, 2026
Economic evaluation of ponatinib vs reference and generic imatinib in front-line management of philadelphia chromosome-positive acute lymphoblastic leukemia: A value dilemmaRosemond Sussana Amamoo, Brielle Schuerman, Mavis Obeng-Kusi, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Compliance with the Veterans Health Administration's Pharmacy Benefit Management guidance for duration of clopidogrel following peripheral vascular interventions: a retrospective cohort studySharon E Kim, Jennifer McCoy, Monique Boudreaux-Kelly, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Assessment of IPAY 2027 Medicare drug price negotiation maximum fair prices with prices in most-favored nation reference countriesNico Gabriel, Kristi Martin, Emma M Cousin, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
The effectiveness of care coordination on medication adherence among high-need, high-cost commercially insured beneficiaries: A randomized controlled trialRintu Saju, Jessica M Harwood, Chi-Hong Tseng, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Cost-effectiveness analysis of treatment strategies initiating with second-generation antipsychotic long-acting injectables in patients with schizophrenia in the United StatesCindy M Chan, Tushita Mayanil, K N Roy Chengappa, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
Medicaid access to Most Favored Nation through the Pfizer agreement: The unanswered issuesJeromie Ballreich, Joseph Levy, Tucker Desmond, et al.Journal of Managed Care & Specialty Pharmacy|February 4, 2020
Determinants of Oral Bisphosphonate Use Beyond 5 YearsMonika A Izano, Joan C Lo, Bruce Ettinger, et al.Journal of Managed Care & Specialty Pharmacy|August 23, 2019
A Payer Perspective of the Costs of Urinary Tract and Skin and Soft Tissue Infections in Adults with Diabetes and the Relationship to Oral Antidiabetic Medication NonadherenceMary L Davis-Ajami, Amy Pakyz, Jun Wu, et al.Journal of Managed Care & Specialty Pharmacy|March 1, 2021
Is it time to replace the star ratings adherence measures?Joel F Farley, Benjamin Y UrickJournal of Managed Care & Specialty Pharmacy|April 29, 2016
Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes DrugsVishal Saundankar, Xiaomei Peng, Haoda Fu, et al.Pageof 185